BiomeBank
Latest round
- Series A
Last raised
- Dec 2022
Total raised
- $7.3M
Investors
- 2
About BiomeBank
Based in Australia, and founded by Sam Costello (CEO), and Rob Bryant in 2018, COST-BRY Pty Ltd. doing business as BiomeBank is a clinical-stage biotechnology company developing microbial therapies to prevent disease by restoring gut microbial ecology. The firm offers a microbiome-based therapy that can be administered to patients during enema or colonoscopy to help treat patients suffering from chronic diseases such as ulcerative colitis, Crohn’s disease, and irritable bowel syndrome. The product is encapsulated and freeze-dried for oral delivery and also offered as a syringe frozen for colonoscopy and enema delivery.
Who invested in BiomeBank
2 investors across 1 round
See all investors in BiomeBank
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 8, 2022
Amount
$7.3M
Investors
Questions about BiomeBank
Who invested in BiomeBank?
BiomeBank has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BiomeBank raised?
BiomeBank has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BiomeBank last raise money?
BiomeBank's most recent round on record is a Series A, in Dec 2022.
What does BiomeBank do?
Based in Australia, and founded by Sam Costello (CEO), and Rob Bryant in 2018, COST-BRY Pty Ltd.
Where is BiomeBank headquartered?
BiomeBank is headquartered in Adelaide, Australia.
Which VCs invest in companies like BiomeBank?
Among active investors with capital left to deploy, Blackbird, AirTree Ventures, Square Peg and Immutable Ventures back biotechnology companies at BiomeBank's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like BiomeBank? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.